Updated: January 26, 2026
How Does Baqsimi Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Summarize with AI
- First: Understanding the Problem Baqsimi Solves
- Step 1: Nasal Delivery and Absorption
- Step 2: Glucagon Enters the Bloodstream
- Step 3: Glucagon Activates Liver Receptors
- Step 4: Glycogen Is Broken Down (Glycogenolysis)
- Step 5: Glucose Is Released Into the Bloodstream
- Why Hepatic Glycogen Stores Matter
- How Is Nasal Absorption Different From Injection?
How does Baqsimi (glucagon nasal powder) raise blood sugar so fast? Learn the science behind its mechanism of action in plain, easy-to-understand language.
When someone with diabetes experiences severe low blood sugar (hypoglycemia), their body can't fix the problem on its own — especially if they're unconscious or can't eat. Baqsimi (glucagon nasal powder 3 mg) is designed to rapidly correct that. But how does a puff of powder into the nose translate into a life-saving rise in blood sugar?
Let's walk through the mechanism of action step by step — no medical degree required.
First: Understanding the Problem Baqsimi Solves
Normally, your body regulates blood sugar through a balance between two hormones:
Insulin lowers blood sugar by moving glucose from the blood into cells.
Glucagon raises blood sugar by telling the liver to release stored glucose.
In people with diabetes who use insulin, this balance can be disrupted. Too much insulin — from a dose miscalculation, missed meal, or unexpected exercise — can cause blood sugar to drop dangerously low. The body's natural glucagon response is often impaired in people with diabetes, making the drop worse. That's where Baqsimi comes in.
Step 1: Nasal Delivery and Absorption
When you activate Baqsimi's intranasal device, it deposits 3 mg of glucagon powder into one nostril. The powder contains two specialized excipients:
Betadex (beta-cyclodextrin): A ring-shaped molecule that surrounds and protects the glucagon peptide, allowing it to dissolve and be absorbed across the nasal mucosa (lining).
Dodecylphosphocholine: A lipid-like molecule that acts as an absorption enhancer, helping the glucagon peptide pass through the nasal lining into the bloodstream.
Importantly, you don't need to inhale Baqsimi — it absorbs through the nasal mucosa automatically. This is why Baqsimi works even if you have nasal congestion from a cold.
Step 2: Glucagon Enters the Bloodstream
Once absorbed, glucagon travels through the bloodstream to the liver. Peak plasma glucagon levels are reached at approximately 15 minutes after Baqsimi administration in adults. In children ages 4-17, peak levels are reached slightly faster — between 15 and 20 minutes.
Step 3: Glucagon Activates Liver Receptors
Glucagon binds to glucagon receptors on liver cells (hepatocytes). These receptors are G-protein coupled receptors that trigger an intracellular signaling cascade:
Glucagon receptor activation increases cyclic AMP (cAMP) inside the liver cell.
Elevated cAMP activates protein kinase A (PKA).
PKA activates glycogen phosphorylase, the enzyme that breaks down glycogen.
Step 4: Glycogen Is Broken Down (Glycogenolysis)
Glycogen is the storage form of glucose in the liver. Your liver stores approximately 100g of glycogen at any given time when well-fed. When glucagon activates the breakdown cascade, this stored glycogen is rapidly converted back into glucose — a process called glycogenolysis.
Step 5: Glucose Is Released Into the Bloodstream
The glucose produced from glycogen breakdown flows out of the liver and into the bloodstream. This rapidly raises blood glucose levels. In clinical trials, Baqsimi raised blood glucose by an average of 140 mg/dL in adults — enough to bring even severely low blood sugar back to safe levels.
Why Hepatic Glycogen Stores Matter
Baqsimi can only work if the liver has glycogen to release. Patients in the following states may have depleted glycogen and may not respond to Baqsimi:
States of starvation or prolonged fasting.
Adrenal insufficiency.
Chronic hypoglycemia with repeated glycogen depletion.
This is why Baqsimi (and all glucagon products) may be less effective after prolonged severe hypoglycemia. Treatment with IV glucose is needed in these cases.
How Is Nasal Absorption Different From Injection?
The bioavailability of intranasal glucagon is lower than injectable glucagon — meaning less of the drug reaches peak plasma concentration via the nasal route. However, clinical trials show this doesn't meaningfully impact effectiveness at treating hypoglycemia. The body needs a functional threshold of glucagon to trigger liver glycogen release — not a maximum dose. Baqsimi delivers enough to achieve this consistently in over 98% of patients.
For more on what Baqsimi is and who needs it, see our guide: What is Baqsimi? Uses, dosage, and what you need to know in 2026.
And if you're looking to fill your Baqsimi prescription, medfinder can help you locate pharmacies near you that have it in stock.
Frequently Asked Questions
Baqsimi delivers glucagon through the nasal lining into the bloodstream. Once in the blood, glucagon binds to receptors on liver cells and triggers a process called glycogenolysis — the breakdown of stored glycogen into glucose, which is then released into the bloodstream. In clinical trials, Baqsimi raised average blood glucose by about 140 mg/dL within approximately 15 minutes.
No. Baqsimi does not need to be inhaled. The powder is deposited in the nasal cavity and absorbed directly through the nasal mucosa (lining). Clinical studies confirm that Baqsimi works even with nasal congestion from a cold, with or without decongestant use, because the absorption doesn't depend on airflow.
Baqsimi reaches peak plasma levels in approximately 15 minutes in adults. The mean time to treatment success (blood glucose increase ≥20 mg/dL from baseline) is approximately 11-14 minutes. Most patients who respond to Baqsimi do so within 15 minutes. If there's no response after 15 minutes, a second dose may be given from a new device while waiting for emergency services.
If the liver has depleted glycogen stores — due to starvation, adrenal insufficiency, or chronic hypoglycemia — Baqsimi may be less effective or ineffective. In these cases, emergency treatment with intravenous glucose is required. Always call 911 after giving Baqsimi so medical professionals can assess the response and give IV glucose if needed.
Yes. The glucagon in Baqsimi is recombinant human glucagon — a 29-amino-acid polypeptide identical to the glucagon naturally produced by the alpha cells of the human pancreas. Its molecular formula is C₁₅₃H₂₂₅N₄₃O₄₉S and molecular weight is approximately 3,483 daltons. It acts through the same receptor pathways as endogenous glucagon.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Baqsimi also looked for:
More about Baqsimi
30,026 have already found their meds with Medfinder.
Start your search today.





